{"id":13329,"date":"2025-09-10T06:03:08","date_gmt":"2025-09-10T06:03:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/13329\/"},"modified":"2025-09-10T06:03:08","modified_gmt":"2025-09-10T06:03:08","slug":"morgans-says-these-asx-shares-could-rise-30","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/13329\/","title":{"rendered":"Morgans says these ASX shares could rise 30%+"},"content":{"rendered":"<p><img width=\"1200\" height=\"675\" src=\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2025\/09\/surprised-16.9-1200x675.jpg\" class=\"attachment-full size-full wp-post-image\" alt=\"A young man wearing a black and white striped t-shirt looks surprised.\" decoding=\"async\" fetchpriority=\"high\"  \/><\/p>\n<p>Image source: Getty Images<\/p>\n<p>If you are looking for outsized returns for your investment portfolio, then read on!<\/p>\n<p>That&#8217;s because the team at Morgans has recently named a couple of ASX shares as buys with the potential to rise by 30% or more between now and this time next year.<\/p>\n<p>Let&#8217;s see what the broker is recommending to clients and why it is feeling upbeat on these names this month. Here&#8217;s what you need to know about them:<\/p>\n<p> Nanosonics Ltd (<a class=\"tickerized-link\" href=\"https:\/\/www.fool.com.au\/tickers\/asx-nan\/\" rel=\"nofollow noopener\" target=\"_blank\">ASX: NAN<\/a>) <\/p>\n<p>Morgans thinks that this infection prevention company&#8217;s shares are being undervalued by the market.<\/p>\n<p>After reviewing its guidance for FY 2026 and taking into account tariff impacts, the broker has retained its buy rating on the ASX share with a trimmed price target of $5.00. Based on its current share price of $3.84, this implies potential upside of 30% for investors over the next 12 months. It commented:<\/p>\n<p>We have updated our forecasts following a deeper review of guidance provided and management commentary, particularly around tariff impacts and CORIS commercialisation timing. While near-term earnings are trimmed, these changes are immaterial to the long-term investment thesis, which remains anchored by recurring revenue growth, installed base expansion, and CORIS&#8217; medium-term potential. Our valuation and target price moderates to A$5.00 (from A$5.50) and we retain our BUY recommendation.<\/p>\n<p> Readytech Holdings Ltd (<a class=\"tickerized-link\" href=\"https:\/\/www.fool.com.au\/tickers\/asx-rdy\/\" rel=\"nofollow noopener\" target=\"_blank\">ASX: RDY<\/a>) <\/p>\n<p>Another ASX share that could offer major upside potential according to Morgans is mission critical software provider Readytech.<\/p>\n<p>Although its performance has underwhelmed this year and its earnings estimates have been trimmed, the broker remains positive on its future.<\/p>\n<p>As a result, it has put a buy rating and $3.00 price target on its shares. Based on its current share price of $2.19, this suggests that a return of 37% is possible between now and this time next year. Morgans commented:<\/p>\n<p>RDY&#8217;s FY25 result was softer than consensus expectations, however Underlying NPATA of $17.3m was broadly in line with MorgF. FY26\/27 guidance was downgraded, and implies a gradual step-up in run-rate as NRR improves (off a challenging FY25) through cloud migration in local government and delivering on its Enterprise wins\/pipeline. Whilst we downgrade our EBITDA forecasts by -12.5% in FY26-FY27F reflecting revised guidance, we see the buildup into FY26 as being manageable. Our target price is reduced to $3.00\/sh (prev. $3.45\/sh), and we retain our BUY rating.<\/p>\n","protected":false},"excerpt":{"rendered":"Image source: Getty Images If you are looking for outsized returns for your investment portfolio, then read on!&hellip;\n","protected":false},"author":2,"featured_media":13330,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[138,15653,111,139,69,12925,12926,12927,12928,15654,15655],"class_list":["post-13329","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-business","tag-category-brokers","tag-new-zealand","tag-newzealand","tag-nz","tag-partner-feeds-msn-9","tag-partner-feeds-newstex","tag-partner-feeds-sharesight","tag-partner-feeds-webull","tag-tickers_global-asx-nan","tag-tickers_global-asx-rdy"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/13329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=13329"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/13329\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/13330"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=13329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=13329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=13329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}